Full name: LAMA5 antisense RNA 1 | Alias Symbol: | ||
Type: non-coding RNA | Cytoband: 20q13.33 | ||
Entrez ID: 101928158 | HGNC ID: HGNC:40334 | Ensembl Gene: ENSG00000228812 | OMIM ID: |
Drug and gene relationship at DGIdb |
Expression of LAMA5-AS1:
Dataset | Gene | EntrezID | Probe | Log2FC | Adj.pValue | Expression |
---|---|---|---|---|---|---|
GSE17351 | LAMA5-AS1 | 101928158 | 242987_x_at | -0.1016 | 0.6279 | |
GSE26886 | LAMA5-AS1 | 101928158 | 242987_x_at | -0.0841 | 0.6633 | |
GSE45670 | LAMA5-AS1 | 101928158 | 242987_x_at | -0.0896 | 0.3771 | |
GSE63941 | LAMA5-AS1 | 101928158 | 242987_x_at | -0.1207 | 0.4118 | |
GSE77861 | LAMA5-AS1 | 101928158 | 242987_x_at | -0.2065 | 0.2083 | |
SRP133303 | LAMA5-AS1 | 101928158 | RNAseq | 0.0185 | 0.9551 | |
SRP219564 | LAMA5-AS1 | 101928158 | RNAseq | -1.0484 | 0.0918 |
Upregulated datasets: 0; Downregulated datasets: 0.
Copy number change of LAMA5-AS1:
No record found for this gene.
Somatic mutations of LAMA5-AS1:
Generating mutation plots.
Highly correlated genes for LAMA5-AS1:
Showing top 20/71 corelated genes with mean PCC>0.5.
Gene1 | Gene2 | Mean PCC | Num. Datasets | Num. PCC<0 | Num. PCC>0.5 |
---|---|---|---|---|---|
LAMA5-AS1 | CCL24 | 0.737614 | 3 | 0 | 3 |
LAMA5-AS1 | TNP2 | 0.705808 | 3 | 0 | 3 |
LAMA5-AS1 | SPNS3 | 0.679246 | 4 | 0 | 3 |
LAMA5-AS1 | ANKRD33 | 0.679122 | 3 | 0 | 3 |
LAMA5-AS1 | ZNF214 | 0.6704 | 3 | 0 | 3 |
LAMA5-AS1 | GPR26 | 0.653264 | 3 | 0 | 3 |
LAMA5-AS1 | LRRC29 | 0.651443 | 4 | 0 | 4 |
LAMA5-AS1 | BIRC7 | 0.650562 | 3 | 0 | 3 |
LAMA5-AS1 | PRR29 | 0.649498 | 4 | 0 | 3 |
LAMA5-AS1 | GSG1 | 0.647869 | 3 | 0 | 3 |
LAMA5-AS1 | RS1 | 0.647048 | 4 | 0 | 3 |
LAMA5-AS1 | APC2 | 0.644999 | 3 | 0 | 3 |
LAMA5-AS1 | CYP2A6 | 0.638902 | 3 | 0 | 3 |
LAMA5-AS1 | THRSP | 0.637191 | 3 | 0 | 3 |
LAMA5-AS1 | IGH | 0.635959 | 3 | 0 | 3 |
LAMA5-AS1 | CCDC116 | 0.63276 | 3 | 0 | 3 |
LAMA5-AS1 | FAM131C | 0.630629 | 3 | 0 | 3 |
LAMA5-AS1 | KCNF1 | 0.627683 | 3 | 0 | 3 |
LAMA5-AS1 | ADORA1 | 0.623304 | 3 | 0 | 3 |
LAMA5-AS1 | WFDC8 | 0.620083 | 4 | 0 | 3 |
For details and further investigation, click here